Page 1

Exhibit 99.1 SURGERY PARTNERS SURGERY PARTNERS , INC . ANNOUNCES FIRST QUARTER 2021 RESULTS ; COMPLETES REFINANCING TRANSACTIONS BRENTWOOD , Tenn . , May 5 , 2021 ( GLOBE NEWSWIRE ) - Surgery Partners , Inc. ( NASDAQ : SGRY ) ( " Surgery Partners " or the " Company " ) , a leading provider of surgical services , today announced results for the first quarter ended March 31 , 2021 . Revenues increased 16.2 % from the prior year period to $ 512.4 million • ° Days adjusted same - facility revenues increased 17.1 % from the prior year period о Days adjusted same - facility case volume increased 8.8 % from the prior year period Net loss attributable to common stockholders was $ 31.3 million ° Adjusted EBITDA increased to $ 72.9 million , growth of approximately 57 % over the prior year period о ° Adjusted EBITDA excluding the benefit from CARES Act grant recognition increased to $ 62.2 million , growth of approximately 34 % over the prior year period 2021 Full year Adjusted EBITDA guidance increased to at least $ 320 million Completes refinancing and amendment of Credit Agreement ° ° Refinances $ 119 million of incremental term loans incurred in April 2020 Extends maturity of existing Credit Agreement until August 2026 Wayne DeVeydt , Executive Chairman of the Board of Surgery Partners , stated , “ Our results continue to demonstrate the value our short - stay facilities provide during these unique times . The Board of Directors could not be more proud of our execution as we continue to provide exceptional patient experience and clinical quality in a low - cost environment . Based on our first quarter 2021 results and our strong liquidity position , this morning we increased our 2021 Adjusted EBITDA guidance to at least $ 320 million , which would represent nearly 25 % growth over 2020 performance . " Eric Evans , Chief Executive Officer , stated , “ Our facilities remain a safe - haven for outpatient surgeries and are increasingly recognized for the value we provide to physicians , patients , health systems and health plans , who appreciate the quality , access and value of our model . Over the past few years , we have been investing in our facilities and new ones to capture this anticipated growth in higher acuity procedures in the outpatient setting . ” " The momentum of our physician recruiting efforts have continued in 2021 , as we added more than 25 % more physicians at our facilities in the first quarter as compared to last year . Our intentional focus on recruiting the right physicians over the past two years is especially evident in our same - facility revenue , which increased approximately 17 % in the first quarter as well as in our expansion of total joint procedures , which grew 122 % in our ASCs during the first quarter . " Tom Cowhey , Chief Financial Officer , commented , “ Our operations teams have been busy in 2021 executing on our growth goals , while our corporate teams have been enhancing our liquidity profile . Our February equity offering gives us ample capital to continue making investments across our business into existing and new lines of service , including investments in robotics , the expansion of our total joint and cardiology programs and , importantly , our development activities . Further , our recently completed refinancing transactions have lowered fixed charges and extended maturities , providing additional financial flexibility for our enterprise as we continue to execute on our Adjusted EBITDA growth goals . " First Quarter 2021 Results Revenues for the first quarter of 2021 increased 16.2 % to $ 512.4 million from $ 441.0 million for the first quarter of 2020. Days adjusted Same - facility Revenues for the first quarter of 2021 increased 17.1 % from the same period last year , with increases in revenue per case and same - facility cases of 7.6 % and 8.8 % , respectively . For the first quarter of 2021 , the Company's net loss attributable to common stockholders and Adjusted EBITDA , was $ 31.3 million and $ 72.9 million , respectively , compared to $ 37.0 million and $ 46.5 million for the same period last year . Adjusted EBITDA benefitted from 1